This study investigates the use of near-infrared (NIR) fluorescence imaging in patients with pancreatic cancer. The purpose of this study is to evaluate the effectiveness of NIR fluorescence imaging as a tool for better visualization of tumors and lymph nodes during surgery. This study evaluates the improvement of surgical outcomes by providing real-time guidance to surgeons.
- Who can participate: Adults over 18 years old who have undergone neoadjuvant treatment for borderline resectable or locally advanced pancreatic cancer are eligible. Participants must be able to communicate in Dutch or English and provide informed consent.
- Study details: Participants will receive a single intravenous dose of the investigational medication SGM-101 before surgery.
- Study timelines and visits: The study will last 3 to 5 days. The study requires 1 visit.